Advertisement

Topics

TapImmune to Present at Two Upcoming Investor Conferences

06:30 EDT 14 Mar 2018 | BioMedReports - Blog

JACKSONVILLE, Fla., March 14, 2018/PRNewswire/ --  TapImmune Inc.(NASDAQ: TPIV), a leading clinical-stage immuno-oncology company with ongoing clinical trials in ovarian

Read more...

Original Article: TapImmune to Present at Two Upcoming Investor Conferences

NEXT ARTICLE

More From BioPortfolio on "TapImmune to Present at Two Upcoming Investor Conferences"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Clinical Approvals
Clinical trials are a set of procedures in medical research conducted to allow safety (or more specifically, information about adverse drug reactions and adverse effects of other treatments) and efficacy data to be collected for health interventions (e.g...